Results 261 to 270 of about 3,396,597 (298)

NMR screening of low molecular weight inhibitors targeting the papain‐like protease (PLPro) of SARS‐CoV‐2

open access: yesFEBS Open Bio, EarlyView.
Papain‐like protease from SARS‐CoV‐2 plays an important role in the cleavage of the viral polyproteins and in the suppression of the host's immune response. Here, we present the results of an NMR screening study. We identified 86 binding compounds, of which five candidates were chosen for in‐depth analysis.
Dennis J. Pyper   +5 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Drug-Drug Interactions: Antiretroviral Drugs and Recreational Drugs

Recent Patents on CNS Drug Discovery, 2015
With the advances in antiretroviral (ARV) therapy, patients with Human Immunodeficiency Virus (HIV) infection are living longer, however, some patients encounter co- morbidities which sometimes require treatment. Therefore, during the treatment with ARV drugs these patients could take several recreational drugs (e.g.
Antonio Siniscalchi   +6 more
openaire   +3 more sources

Therapeutic Drug Monitoring and Drug–Drug Interactions Involving Antiretroviral Drugs

Antiviral Therapy, 2005
The consensus of current international guidelines for the treatment of HIV infection is that data on therapeutic drug monitoring (TDM) of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) provide a framework for the implementation of TDM in certain defined scenarios in clinical practice. However, the utility of TDM
Boffito, M   +11 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy